KOL strategy & medical devices in France
- contact901451
- 2 days ago
- 4 min read
In one of Europe’s most tightly regulated environments, medical device communication in France leaves no room for improvisation. Between ANSM, oversight, MDR requirements and strict transparency rules governing KOL (Key Opinion Leader) relationships, every message must be strategic, controlled and scientifically robust. At Popmyfilm, we turn these constraints into business acceleration drivers through structured KOL strategies and compliant audiovisual content designed for scalable European deployment. THE POPMYFILM EDGE: We build compliance into the strategy — not as a last-minute fix.
France: a market of excellence… under strict regulation
In France, the concept of advertising for a medical device is broadly defined (Public Health Code – L5213-1). Any information intended to promote the use of a device may be considered promotional. The ANSM differentiates according to target audience, risk class, and reimbursement status. As a result, what works elsewhere in Europe may be prohibited in France. Since 2016, Popmyfilm has integrated this regulatory logic into its medical productions (https://www.popmyfilm.com/en/medical). We structure messaging from the script stage — not after the edit is completed.
THE POPMYFILM EDGE:Â We write for regulators as much as for the market.
From CE marking to market acess: storytelling follows the regulatory pathway
A medical device does not launch like a consumer product. It follows a structured sequence: MDR compliance (Règlement UE 2017/745 – MDR), indication validation, reimbursement positioning, and progressive clinical adoption. Communication must support each phase — highlighting clinical data, explaining the procedure, and clarifying therapeutic positioning. At Popmyfilm, we translate your regulatory roadmap into an editorial roadmap, ensuring the right content is produced at the right time. Example: our productions on left atrial appendage closure (blog: https://www.popmyfilm.com/en/blog ). THE POPMYFILM EDGE:  nous alignons le storytelling sur votre roadmap réglementaire.
KOL: scientific credibility without the advertising angle
Since 2016, we have interviewed dozens — even hundreds — of KOLs across Europe. A high-performing interview is not designed to sell; it is designed to clarify. The KOL contextualizes the data, explains patient selection, outlines limitations and real-world practice conditions. This rigor strengthens peer credibility and accelerates adoption. Our methodology transforms medical expertise into a strategic adoption tool — without crossing promotional boundaries.
THE POPMYFILM EDGE:Â Â We turn medical expertise into credible adoption leverage.
Interviewing a KOL means structuring proof
A medical interview is never improvised. It is built around a validated angle, secured claims, a structured narrative flow and relevant visual evidence: clinical b-roll, imaging, 3D mechanism-of-action animation. We prepare every intervention as a structured demonstration, where precision of language and contextual framing make the difference. The result: commercially usable content, free of overstatement and regulatory fragility.
See our work: https://www.popmyfilm.com/en/réalisations
THE POPMYFILM EDGE:Â Â We structure clinical proof without ever overpromising.
Compliance & distribution: choosing the right environment
In France, distribution strategy is inseparable from content strategy. Certain formats must remain strictly restricted to healthcare professionals through secured platforms or controlled channels (internal training, congresses, newsletters, sales enablement). Additionally, the Transparence Santé database requires rigorous governance of KOL relationships. At Popmyfilm, we integrate these parameters from the concept phase to eliminate downstream risk and ensure compliant, effective dissemination.
THE POPMYFILM EDGE:Â Â We secure distribution as rigorously as content.
France-Ready formats: inform, educate, standardize
Technical tutorials, 3D mechanism-of-action animations, KOL masterclasses, HCP FAQs, anonymized clinical case studies — these formats support business objectives without crossing into prohibited promotion. The goal is not visibility for its own sake, but friction reduction: clarifying clinical value, standardizing field messaging and accelerating understanding. Our approach is educational, structured and performance-driven.
THE POPMYFILM EDGE:Â Â We replace promotion with strategic education.
One shoot, a galaxy of assets: smart production
Each production is designed with an asset-first mindset: master film, thematic capsules, congress extracts, short digital formats, multilingual adaptations for European deployment. This anticipation allows budget optimization while maintaining scientific rigor and visual consistency over 12–24 months. We constantly seek intelligent production models that create more value from the same investment — without compromising quality.
THE POPMYFILM EDGE:Â Â We design every shoot to maximize impact and minimize budget.
Conclusion: turning compliance into adoption leverage
French regulation demands clarity, precision and traceability. Rather than a barrier, it is a quality filter. By structuring a robust KOL strategy and compliant video content from the outset, clinical adoption can accelerate in a controlled and sustainable way. Popmyfilm designs editorial systems tailored to France and scalable across Europe. Compliance is not a constraint — it is a competitive advantage when mastered.
THE POPMYFILM EDGE:Â Â We turn regulatory constraint into competitive advantage.
Ready to communicate about your project?
Let’s connect and design your strategy together!
"What They Say About Us" Discover our client testimonials !
Explore Our Work
As video production specialists, we help you communicate effectively through tailored, high-impact content. Explore our projects and get inspired for your next campaigns. Get in touch!​
@BostonScientific @Medtronic @Abbott @PhilipsHealthcare @GEHealthcare @SiemensHealthineers @EdwardsLifesciences @JohnsonJohnsonMedTech @TerumoMedical @BDMedical @StrykerCorp @GuerbetGroup @BiotronikGlobal @LivaNovaPLC @MicroPortMedTech @AlconGlobal @RocheDiagnostics @Novartis @OtsukaMedicalDevices @BayerHealth @OlympusCorporation @ZimmerBiomet @CookMedicalGlobal @TeleflexInc @MeritMedical @CardinalHealthIntl @FreseniusMedicalCareAG @IntuitiveSurgicalInc @SmithNephewPLC @ExactechGlobal